ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.317,75
0,18%
Dow Jones
39.860,60
0,14%
Euro vs US Dollar
1,08535
-0,06%
Bitcoin
69.910,05
-2,15%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) News

ASMB

Assembly Biosciences (ASMB)

Assembly Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ASMB
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
08/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
08/05/202422h05GlobeNewswire Inc.Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
28/03/202421h05GlobeNewswire Inc.Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
08/02/202414h00GlobeNewswire Inc.Assembly Biosciences Announces Effective Date of Reverse Stock SplitNASDAQ:ASMBAssembly Biosciences Inc
02/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
19/01/202417h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
17/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
04/01/202414h00GlobeNewswire Inc.Assembly Biosciences Provides Anticipated Development Milestones for 2024NASDAQ:ASMBAssembly Biosciences Inc
21/12/202322h06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ASMBAssembly Biosciences Inc
21/12/202322h01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202322h10Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
07/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
22/11/202322h12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
22/11/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
10/11/202322h05GlobeNewswire Inc.Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ASMBAssembly Biosciences Inc
10/11/202314h00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
08/11/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
08/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
08/11/202322h05GlobeNewswire Inc.Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
08/11/202314h00GlobeNewswire Inc.Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical OfficerNASDAQ:ASMBAssembly Biosciences Inc
03/11/202321h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
31/10/202321h19Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ASMBAssembly Biosciences Inc
31/10/202317h38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
17/10/202314h44Dow Jones NewsAssembly Biosciences Shares Soar Premarket on Gilead PactNASDAQ:ASMBAssembly Biosciences Inc
17/10/202313h51Dow Jones NewsGilead Taking Stake in Assembly Bio Under Antiviral CollaborationNASDAQ:ASMBAssembly Biosciences Inc
17/10/202313h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
17/10/202313h00Business WireGilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral DiseasesNASDAQ:ASMBAssembly Biosciences Inc
11/10/202314h00GlobeNewswire Inc.Assembly Biosciences to Present New Data at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ASMB

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
TG
DTE
Deutsche Telekom
NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
TG
CBK
Commerzbank
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
PM
XAUUSD
Gold vs US Dollar
TG
DBK
Deutsche Bank
TG
TUI1
Tui
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten